Search - tctmd.com

Displaying 141 - 150 of 150

Sort: Relevancy | Date

News Daily News

La Definición Universal de IM se Posiciona en Favor del Cangrelor en las PCI

March 20, 2012

Reduced Immediate Ischemic Events with Cangrelor in PCI: Pooled Analysis of the CHAMPION Trials Using the Universal Definition of MI

Presentation

Reduced Immediate Ischemic Events with Cangrelor in PCI: Pooled Analysis of the CHAMPION Trials Using the Universal Definition of MI

Presenter: 35236|Harvey White

March 16, 2012

Menores Episodios Isquémicos Inmediatos con el Cangrelor en las PCI: Análisis Conjunto de los Ensayos Champion usando la Definición Universal de IM

Presentation

Menores Episodios Isquémicos Inmediatos con el Cangrelor en las PCI: Análisis Conjunto de los Ensayos Champion usando la Definición Universal de IM

Presenter: Harvey D. White

March 16, 2012

Puenteando la Terapia Antiplaquetaria con Cangrelor en Pacientes que se someten a Cirugía Cardíaca

Presentation

Puenteando la Terapia Antiplaquetaria con Cangrelor en Pacientes que se someten a Cirugía Cardíaca

Presenter: Dominick J. Angiolillo

January 16, 2012

Bridging Antiplatelet Therapy with Cangrelor in Patients Undergoing Cardiac Surgery

Presentation

Bridging Antiplatelet Therapy with Cangrelor in Patients Undergoing Cardiac Surgery

Presenter: Dominick J. Angiolillo

January 16, 2012

News Daily News

BRIDGE Published: Cangrelor Promising Option as Bridging Therapy

January 16, 2012

News Conference News

BRIDGE: Cangrelor Provides Effective Maintenance of Platelet Inhibition Without Major Bleeding

November 09, 2011

News Industry News

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

November 08, 2011

News Industry News

Cangrelor provides effective maintenance of platelet inhibition without major bleeding for patients who require bypass surgery

November 08, 2011

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

CME

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.